By Josh White
Date: Tuesday 08 Jul 2025
(Sharecast News) - Niox Group reported strong first-half trading on Tuesday, driven by robust growth in both clinical and research revenues, and said it remained confident in its strategic plans despite some uncertainty around research demand.
Niox Group reports strong start to 2025 | 14-May-2025 | ShareCast |
Niox ends sale process as Keensight steps back | 11-Apr-2025 | ShareCast |
Niox reports solid set of full-year results | 01-Apr-2025 | ShareCast |
Niox confirms approach from Keensight, enters fo... | 20-Mar-2025 | ShareCast |
Niox flags strong year, announces board changes | 16-Jan-2025 | ShareCast |
Total Voting Rights | 01-Aug-2025 | 07:00 | RNS |
PDMR/PCA Shareholding | 22-Jul-2025 | 13:48 | RNS |
Trading Update | 08-Jul-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 26-Jun-2025 | 16:15 | RNS |
Holding(s) in Company | 25-Jun-2025 | 15:45 | RNS |
Circassia raises £200m in landmark biotech IPO | 14-Mar-2014 | The Independent |
Cat allergy group raises £200m in float | 14-Mar-2014 | Telegraph |
No recent information was found.
No recent information was found.
Currency | UK Pounds |
Share Price | 70.00p |
Change Today | -0.20p |
% Change | -0.28 % |
52 Week High | 76.00p |
52 Week Low | 54.60p |
Volume | 772,365 |
Shares Issued | 417.78m |
Market Cap | £292.45m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 3 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 5 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 15-May-25 | 23-May-24 |
Paid | 16-Jun-25 | 24-Jun-24 |
Amount | 1.25p | 1.00p |
Time | Volume / Share Price |
16:35 | 15 @ 70.00p |
16:35 | 11,270 @ 70.00p |
16:35 | 644 @ 70.00p |
16:35 | 47 @ 70.00p |
16:35 | 1,065 @ 70.00p |
You are here: research